Res in IBS 9mar17.sav

Dataset from N=74 (+30 non-participants) subjects with irritable bowel syndrome (Rome III criteria). Of these, n=54 underwent gut-directed hypnotherapy. <br>Group A (n=37) was assessed pre hypnotherapy (T1) and 10 months post hypnotherapy (T2). Group B (n=37) was assessed as a control group at T2. A subset of group 2 (n=16) received also hypnotherapy, and was examined respectively after 10 months (T3). <br><br>Assessed variables comprise factors of resilience:<br>10 item CDRISC (resilience)<br>BFI-K (neuroticism scale)<br>SWE (self-efficacy)<br>STCI (trait cheerfulness scale)<br>CERQ (adaptive/dysfunctional emotion regulation strategies)<br>FSozU (social support)<br><br>and 2. symptom severity, affective status, and wellbeing<br> <br>HADS (psychological distress)<br>IBS-SSS (IBS severity)<br>quality of life visual analogue scales<br><br>All available scores (raw scores or standardized) from these questionnaires are in the file. <br><br>In Group A at T1, IBS-SSS and resilience measures were not captured. <br>Resilience factors were merged to compound scores unweighted (additional) and weighted based on regression coefficients from PCA. Scores and regression coefficients are in the file. Sensitive data such as diagnoses, socioeconomic variables or birth and examination dates were taken out of the file to safeguard anonymity and patient rights.